Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 12.10.2013 | EN | Official Journal of the European Union | C 296/3 |

---

Prior notification of a concentration

(Case COMP/M.6944 — Thermo Fisher Scientific/Life Technologies)

(Text with EEA relevance)

2013/C 296/04

|  |  |
| --- | --- |
| 1. | On 7 October 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004[(1)](#ntr1-C_2013296EN.01000301-E0001) by which the undertaking Thermo Fisher Scientific Inc. (‘Thermo Fisher’, USA) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Life Technologies Corp. (‘Life Technologies’, USA) by means of purchase of shares. |

|  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- |
| 2. | The business activities of the undertakings concerned are:   |  |  | | --- | --- | | — | for Thermo Fisher: global production and supply of analytical instruments, scientific equipment, consumables, reagents, services and software for research, analysis, discovery and diagnostics, |  |  |  | | --- | --- | | — | for Life Technologies: global biotechnology tools company involved in production and supply of products for a range of life science applications, including gene sequencing, polymerase chain reaction, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications, forensics and animal, food, pharmaceutical and water testing analysis. | |

|  |  |
| --- | --- |
| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved. |

|  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- |
| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6944 — Thermo Fisher Scientific/Life Technologies, to the following address:   |  | | --- | | European Commission | | Directorate-General for Competition | | Merger Registry | | 1049 Bruxelles/Brussel | | BELGIQUE/BELGIË | |

---

[Top](#document1)